-
The Application of 2d Mxene Nanosheet -Based Thermosensitive Gel Delivery System Loaded with Cisplatin and Imiquimod for Lung Cancer
24 May 2024 14:04 GMT
… lung cancer are small cell lung cancer and non-small cell lung cancer … used hyaluronic acid and Doxorubicin (DOX) to modify … Photodynamic Therapy for Lung Cancer Treatment. Anticancer Agents … Small-Cell Lung Cancer: a Systematic Review. Clin Lung Cancer. 2017 …
-
FDA APPROVES IMDELLTRA , THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
17 May 2024 05:23 GMT
…
American Cancer Society. Lung Cancer Survival Rates. www … with small cell lung cancer. Lung Cancer. 2020;147:237 … doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer … lung cancer progression after 2 lines of therapy. Lung Cancer …
-
Bevacizumab by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
17 May 2024 03:08 GMT
… squamous non-small cell lung cancer (with carboplatin and … carcinoma, non-small cell lung cancer, metastatic colorectal cancer, … topotecan or pegylated liposomal doxorubicin is indicated for the … adjuvant non small cell lung cancer (NSCLC), metastatic liver …
-
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
20 Apr 2024 12:31 GMT
… ; Caelyx, PEGylated liposomal doxorubicin; EGFR, endothelial growth … lung cancer: current treatment and future advances. Transl Lung Cancer Res … with small-cell lung cancer. Clin Lung Cancer. 2003;5(2 … . Non-small-cell lung cancers: a heterogeneous set of …
-
2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin
06 Jun 2024 15:55 GMT
… reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled … EGFR-mutant non-small-cell lung cancer. Pharmacol Res. 2021;170: … . Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug …
-
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
04 Apr 2024 11:01 GMT
… non-small cell lung cancers (adenocarcinoma). Despite … been challenging.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … paclitaxel followed by doxorubicin or epirubicin and …
-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… patients with metastatic lung cancer, lung cancer continues to … cycles.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … paclitaxel followed by doxorubicin or epirubicin and …
-
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
21 Mar 2024 11:01 GMT
… non-small cell lung cancer. We sincerely thank … intolerable toxicity.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … paclitaxel followed by doxorubicin or epirubicin and …
-
BP8 Sources Bird’s Nest Products from Chinese State-Owned Conglomerate China National Pharmaceutical Group Corporation (Commonly Known as Sinopharm)
06 Jun 2024 04:43 GMT
… Cell Lung Cancer (SCLC)
Small cell lung cancer is … with small cell lung cancer. Lung Cancer. 2020;147:237 … doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer … lung cancer progressing after 2 lines of therapy. Lung Cancer …
-
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
05 Jun 2024 23:55 GMT
… classical chemotherapy drugs such as doxorubicin and methotrexate with the benefit … being evaluated for small cell lung cancer, which is a particularly recalcitrant …